Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI114448

Interaction of sulfonamide and sulfone compounds with Toxoplasma gondii dihydropteroate synthase.

C J Allegra, D Boarman, J A Kovacs, P Morrison, J Beaver, B A Chabner, and H Masur

Medicine Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.

Find articles by Allegra, C. in: PubMed | Google Scholar

Medicine Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.

Find articles by Boarman, D. in: PubMed | Google Scholar

Medicine Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.

Find articles by Kovacs, J. in: PubMed | Google Scholar

Medicine Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.

Find articles by Morrison, P. in: PubMed | Google Scholar

Medicine Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.

Find articles by Beaver, J. in: PubMed | Google Scholar

Medicine Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.

Find articles by Chabner, B. in: PubMed | Google Scholar

Medicine Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.

Find articles by Masur, H. in: PubMed | Google Scholar

Published February 1, 1990 - More info

Published in Volume 85, Issue 2 on February 1, 1990
J Clin Invest. 1990;85(2):371–379. https://doi.org/10.1172/JCI114448.
© 1990 The American Society for Clinical Investigation
Published February 1, 1990 - Version history
View PDF
Abstract

Toxoplasma gondii is a common protozoan disease that often causes life-threatening disease, particularly among patients with the acquired immunodeficiency syndrome. This study demonstrates that the dihydropteroate synthase in T. gondii is kinetically distinct from the enzyme characterized from other sources and can be highly purified with a high yield using sequential dye-affinity chromatography. Conditions have been identified that allow for stabilization of the purified enzyme, and its physical characteristics have been elucidated. The molecular weight of the native protein was 125,000 and the protein appeared to contain both dihydropteroate synthase and 6-hydroxymethyl-dihydropterin pyrophosphokinase activities. The sulfonamide class of compounds vary in inhibitory potency by more than three orders of magnitude. Sulfathiazole, sulfamethoxazole, and sulfamethazine, with 50% inhibitory concentrations (IC50's) of 1.7, 2.7, and 5.7 microM, respectively, represent the most potent of this class of inhibitors. Several sulfone analogues, including dapsone, were identified as highly potent inhibitors with IC50's less than 1 microM. The results of these cell-free experiments were corroborated by investigating the metabolic inhibition produced by the various inhibitors in intact organisms. The qualitative and quantitative relations among the inhibitors were preserved in both the cell-free and intact cell assay systems. These studies suggest that the sulfones may be important therapeutic agents for the treatment of toxoplasmosis.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 371
page 371
icon of scanned page 372
page 372
icon of scanned page 373
page 373
icon of scanned page 374
page 374
icon of scanned page 375
page 375
icon of scanned page 376
page 376
icon of scanned page 377
page 377
icon of scanned page 378
page 378
icon of scanned page 379
page 379
Version history
  • Version 1 (February 1, 1990): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts